HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stan Blockhuys Selected Research

Erythema

6/2007Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stan Blockhuys Research Topics

Disease

1Lamellar Ichthyosis (Harlequin Ichthyosis)
01/2009
1Inflammation (Inflammations)
01/2009
1Necrosis
01/2009
1Erythema
06/2007
1Seborrheic Dermatitis
06/2007

Drug/Important Bio-Agent (IBA)

1Interleukin-1alpha (Interleukin 1 alpha)IBA
01/2009
1cellular retinoic acid binding protein IIIBA
01/2009
1Retinoic Acid 4-Hydroxylase (CYP26B1)IBA
01/2009
1Messenger RNA (mRNA)IBA
01/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2009
1Therapeutic UsesIBA
01/2009
1liarozoleIBA
01/2009
1Keratins (Keratin)IBA
01/2009
1RetinoidsIBA
01/2009
1Immunoglobulin A (IgA)IBA
06/2007
1SteroidsIBA
06/2007
1Ketoconazole (Nizoral)FDA LinkGeneric
06/2007